Finance

Lists
Q2 2026 earnings • released • EPS miss -332.68% • Revenue miss -7.44%
See results
MYGN:NASDAQ
Myriad Genetics Inc
$2.86
-46.74%
(-2.51) 1D
$2.91
+1.75% (+0.050)
Pre-market
Closed: Jul 31, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MYGN...
Open
$3.10
High
$3.26
Low
$2.81
Mkt. cap
270.12M
Avg. vol.
1.36M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.81
EPS
-$1.20
Beta
1.64
Shares outstanding
94.45M
No. of employees
3K
Open
$3.10
High
$3.26
Low
$2.81
Mkt. cap
270.12M
Avg. vol.
1.36M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.81
EPS
-$1.20
Beta
1.64
Shares outstanding
94.45M
No. of employees
3K
News stories
From sources across the web
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com
Analyst ratings
Based on 6 analysts giving stock ratings to MYGN in the past 3 months
Hold
Buy
2
Hold
3
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MYGN in the last 3 months.
Highest
Current $2.86
$10.00 (+249.65%)
Average
$6.40 (+123.78%)
Lowest
$4.00 (+39.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
$8.50
+197.2%
07/31/2026
Kyle Boucher
TD Cowen
Hold
Reiterated
$4.00
+39.9%
07/31/2026
Daniel Brennan
TD Cowen
Hold
Reiterated
$4.00
+39.9%
07/31/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$5.50
+92.3%
07/29/2026
Michael Ryskin
Bank of America Securities
Sell
Maintained
$4.00
+39.9%
07/13/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
05/06/2026
William Bonello
Craig-Hallum
Buy
Reiterated
$10.00
+249.7%
05/06/2026
Lu Li
UBS
Hold
Maintained
$6.00
+109.8%
02/25/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.25 / -$0.06
-332.68%miss
Revenue / Est. (USD)
190.70M / 206.03M
-7.44%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
205.70M
209.80M
200.40M
190.70M
Cost of goods sold
61.90M
63.00M
62.80M
-
Cost of revenue
61.90M
63.00M
62.80M
-
Research and development expenses
28.20M
25.50M
27.10M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
138.90M
124.30M
135.80M
-
Operating expense
167.10M
149.80M
162.90M
-
Total operating expenses
229.00M
212.80M
225.70M
-
Operating income
-23.30M
-3.00M
-25.30M
-
Other non operating income
400.00K
400.00K
-
-
EBT including unusual items
-26.20M
-8.90M
-34.10M
-
EBT excluding unusual items
-26.20M
-6.20M
-28.70M
-
Income tax expense
1.20M
-1.00M
-
-
Effective tax rate
-4.58%
11.24%
-
-
Other operating expenses
-
-
-
-
Net income
-27.40M
-7.90M
-34.10M
-
Net profit margin
-13.32%
-3.77%
-17.02%
-22.65%
Earnings per share
-
0.04
-0.09
-0.25
Interest and investment income
500.00K
800.00K
700.00K
-
Interest expense
-3.80M
-4.40M
-4.10M
-
Net interest expenses
-3.30M
-3.60M
-3.40M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.70M
9.60M
-12.80M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps